Virotherapy News and Research

RSS
Virotherapy is treatment using a virus that has been changed in the laboratory to find and destroy cancer cells without harming healthy cells. It is a type of targeted therapy. Also called oncolytic virotherapy, oncolytic virus therapy, and viral therapy.
IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

IDIBELL scientists develop oncolytic virus capable of redirecting immune system to attack cancer cells

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

Study ignores possibility that drugs, chemicals affect sexes differently

Study ignores possibility that drugs, chemicals affect sexes differently

Viralytics enters into clinical trial collaboration agreement with MSD

Viralytics enters into clinical trial collaboration agreement with MSD

Oncolytic virotherapy lends benefits to melanoma patients

Oncolytic virotherapy lends benefits to melanoma patients

UCL research opens up new way to treat neurological disorders

UCL research opens up new way to treat neurological disorders

Transgene welcomes SillaJen’s intention to acquire Jennerex

Transgene welcomes SillaJen’s intention to acquire Jennerex

Viralytics releases financial results for 2013

Viralytics releases financial results for 2013

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Natural killer cell response detrimental to glioblastoma virotherapy

Natural killer cell response detrimental to glioblastoma virotherapy

Cancer therapy with common cold virus

Cancer therapy with common cold virus

Advaxis, Vibalogics to develop storage-stable formulation for live Listeria vaccines

Advaxis, Vibalogics to develop storage-stable formulation for live Listeria vaccines

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug

Scientists shrink distant sarcomas with genetically reprogrammed herpes virus and anti-vascular drug

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

Scientists use genetically reprogrammed herpes virus to shrink distant sarcomas

South Dakota State University mathematicians design mathematical models to treat cancer

South Dakota State University mathematicians design mathematical models to treat cancer

Combining antiangiogenic cancer therapy with oncolytic virotherapy leads to regression of tumors

Combining antiangiogenic cancer therapy with oncolytic virotherapy leads to regression of tumors

Global market for oncology drugs is forecast to reach $80 billion by 2050

Global market for oncology drugs is forecast to reach $80 billion by 2050

Trial of new ‘combo’ treatment for hepatitis C

Trial of new ‘combo’ treatment for hepatitis C

Tamed virus wipes out cancer safely

Tamed virus wipes out cancer safely

Cimzia approved in U.S. for rheumatoid arthritis

Cimzia approved in U.S. for rheumatoid arthritis